Regeneron Rips DOJ's FCA Suit As 'Divorced From Reality'
By Elliot Weld · July 19, 2024, 2:44 PM EDT
Regeneron Pharmaceuticals Inc. has told a Massachusetts federal judge that a False Claims Act suit brought by the U.S. Department of Justice claiming the company withheld information about a drug's average...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login